Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Hb target roll call

Hb target roll call

Hb target roll callFDA's first question (1a) to an advisory panel last week was should ESA product

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE